Market News

  • Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

    Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday. ... updated: Fri, 21 Feb 2025 18:48:03 GMT

  • UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months

    It extends a tumultuous period for UnitedHealth marked by the killing of a top executive, a costly cyberattack against its su... updated: Fri, 21 Feb 2025 20:56:28 GMT

  • IMAX CEO expects $1.2 billion in box office receipts this year, the best in the company's history

    Aiding IMAX's lofty box office goals is the Chinese title "Ne Zha 2," which has already garnered $1.6 billion globally, inclu... updated: Fri, 21 Feb 2025 16:42:31 GMT

  • Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

    The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injecti... updated: Fri, 21 Feb 2025 20:57:12 GMT

Company News

Alpha Global Wealth Receive Industry Awards and Recognition

March 2020 - We are delighted to announce that Alpha Global Wealth has been officially recognised and awarded two prestigious industry accolades.

The International Investor Magazine awards for 2020 have voted and presented Alpha Global Wealth with the following awards:

James Barnes, director of Alpha Global Wealth “We are delighted by receiving these two awards, especially for being recognised for ‘Excellence in Customer Satisfaction’ as we strive to ensure lasting relationships and provide industry leading advice, service and the all important ‘personal touch’ missing from many of our competitors.

Alpha Global Access
Our distinctive approach to investment management
Trustpilot
  • Alpha Global Wealth SA
  • Chemin du Pavillon 5
  • Le Grand-Saconnex
  • 1218 Geneva
  • Switzerland
Talk to us